CYTOKINETICS INC — Director's Dealing 2021

Mar 4, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2021-03-02

Reporting Person: SCHLOSSBERG MARK A (SVP - Legal & General Counsel)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-03-02	Common Stock	A	25000	$0.0	Acquired	55000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-03-02	Incentive Stock Option (right to buy)	$19.42	A	10129	Acquired	2031-03-01	Common Stock (10129)	Direct
2021-03-02	Non-Qualified Stock Option (right to buy)	$19.42	A	34871	Acquired	2031-03-01	Common Stock (34871)	Direct

Footnotes

F1: Comprised of restricted stock units that will vest over 3 years, with 40% vesting on the 1-year anniversary of the grant, an additional 40% vesting on the 2-year anniversary of the grant, and the final 20% vesting on the 3-year anniversary of the grant.

F2: This option shall vest and become exercisable over 4 years, with shares divided into equal monthly installments, such that the option shall be 100% vested four years from the date of grant.